KAT3_HUMAN - dbPTM
KAT3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KAT3_HUMAN
UniProt AC Q6YP21
Protein Name Kynurenine--oxoglutarate transaminase 3
Gene Name KYAT3 {ECO:0000312|HGNC:HGNC:33238}
Organism Homo sapiens (Human).
Sequence Length 454
Subcellular Localization
Protein Description Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). May catalyze the beta-elimination of S-conjugates and Se-conjugates of L-(seleno)cysteine, resulting in the cleavage of the C-S or C-Se bond (By similarity). Has transaminase activity towards L-kynurenine, tryptophan, phenylalanine, serine, cysteine, methionine, histidine, glutamine and asparagine with glyoxylate as an amino group acceptor (in vitro). Has lower activity with 2-oxoglutarate as amino group acceptor (in vitro) (By similarity)..
Protein Sequence MFLAQRSLCSLSGRAKFLKTISSSKILGFSTSAKMSLKFTNAKRIEGLDSNVWIEFTKLAADPSVVNLGQGFPDISPPTYVKEELSKIAAIDSLNQYTRGFGHPSLVKALSYLYEKLYQKQIDSNKEILVTVGAYGSLFNTIQALIDEGDEVILIVPFYDCYEPMVRMAGATPVFIPLRSKPVYGKRWSSSDWTLDPQELESKFNSKTKAIILNTPHNPLGKVYNREELQVIADLCIKYDTLCISDEVYEWLVYSGNKHLKIATFPGMWERTITIGSAGKTFSVTGWKLGWSIGPNHLIKHLQTVQQNTIYTCATPLQEALAQAFWIDIKRMDDPECYFNSLPKELEVKRDRMVRLLESVGLKPIVPDGGYFIIADVSLLDPDLSDMKNNEPYDYKFVKWMTKHKKLSAIPVSAFCNSETKSQFEKFVRFCFIKKDSTLDAAEEIIKAWSVQKS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2 (in isoform 3)Acetylation-8.5522814378
7Phosphorylation-MFLAQRSLCSLSGR
-CCCHHHHHHHHCCH
22.9625599653
10PhosphorylationLAQRSLCSLSGRAKF
CHHHHHHHHCCHHHH
30.7525599653
12PhosphorylationQRSLCSLSGRAKFLK
HHHHHHHCCHHHHHH
15.2218491316
22PhosphorylationAKFLKTISSSKILGF
HHHHHHHCCCCCCCC
33.5230631047
24PhosphorylationFLKTISSSKILGFST
HHHHHCCCCCCCCCC
19.54-
32PhosphorylationKILGFSTSAKMSLKF
CCCCCCCCCCEEEEE
25.3730631047
38MethylationTSAKMSLKFTNAKRI
CCCCEEEEECCCCEE
42.72-
74UbiquitinationNLGQGFPDISPPTYV
ECCCCCCCCCCCHHH
52.3021890473
74AcetylationNLGQGFPDISPPTYV
ECCCCCCCCCCCHHH
52.3019608861
74UbiquitinationNLGQGFPDISPPTYV
ECCCCCCCCCCCHHH
52.3019608861
76PhosphorylationGQGFPDISPPTYVKE
CCCCCCCCCCHHHHH
32.0126657352
79PhosphorylationFPDISPPTYVKEELS
CCCCCCCHHHHHHHH
44.3127251275
80PhosphorylationPDISPPTYVKEELSK
CCCCCCHHHHHHHHH
18.4627251275
82AcetylationISPPTYVKEELSKIA
CCCCHHHHHHHHHHH
34.7519608861
82 (in isoform 1)Ubiquitination-34.7521890473
82UbiquitinationISPPTYVKEELSKIA
CCCCHHHHHHHHHHH
34.7521906983
82 (in isoform 2)Ubiquitination-34.7521890473
86PhosphorylationTYVKEELSKIAAIDS
HHHHHHHHHHHHHHH
25.8724076635
87 (in isoform 2)Ubiquitination-49.3321890473
87 (in isoform 1)Ubiquitination-49.3321890473
87UbiquitinationYVKEELSKIAAIDSL
HHHHHHHHHHHHHHH
49.3321906983
93PhosphorylationSKIAAIDSLNQYTRG
HHHHHHHHHHHHCCC
24.0928857561
99MethylationDSLNQYTRGFGHPSL
HHHHHHCCCCCCHHH
33.24-
108 (in isoform 2)Ubiquitination-49.2321890473
108 (in isoform 1)Ubiquitination-49.2321890473
108UbiquitinationFGHPSLVKALSYLYE
CCCHHHHHHHHHHHH
49.2321890473
108AcetylationFGHPSLVKALSYLYE
CCCHHHHHHHHHHHH
49.2319608861
116SuccinylationALSYLYEKLYQKQID
HHHHHHHHHHHHHCC
38.65-
116SuccinylationALSYLYEKLYQKQID
HHHHHHHHHHHHHCC
38.65-
116AcetylationALSYLYEKLYQKQID
HHHHHHHHHHHHHCC
38.6519608861
120 (in isoform 1)Ubiquitination-35.3521890473
120 (in isoform 2)Ubiquitination-35.3521890473
120UbiquitinationLYEKLYQKQIDSNKE
HHHHHHHHHCCCCCC
35.3521906983
189PhosphorylationPVYGKRWSSSDWTLD
CCCCCCCCCCCCCCC
24.8128450419
190PhosphorylationVYGKRWSSSDWTLDP
CCCCCCCCCCCCCCH
25.9228450419
191PhosphorylationYGKRWSSSDWTLDPQ
CCCCCCCCCCCCCHH
31.4828450419
194PhosphorylationRWSSSDWTLDPQELE
CCCCCCCCCCHHHHH
26.6928450419
203UbiquitinationDPQELESKFNSKTKA
CHHHHHHHHCCCCEE
38.9121906983
203 (in isoform 1)Ubiquitination-38.9121890473
215PhosphorylationTKAIILNTPHNPLGK
CEEEEECCCCCCCCC
23.60-
222UbiquitinationTPHNPLGKVYNREEL
CCCCCCCCCCCHHHH
49.59-
280OtherITIGSAGKTFSVTGW
EEEECCCCEEEEEEE
46.22-
280N6-(pyridoxal phosphate)lysineITIGSAGKTFSVTGW
EEEECCCCEEEEEEE
46.22-
396UbiquitinationNNEPYDYKFVKWMTK
CCCCCCHHHHHHHHH
40.56-
396AcetylationNNEPYDYKFVKWMTK
CCCCCCHHHHHHHHH
40.5627452117
399UbiquitinationPYDYKFVKWMTKHKK
CCCHHHHHHHHHCCC
34.09-
399AcetylationPYDYKFVKWMTKHKK
CCCHHHHHHHHHCCC
34.0925953088
406UbiquitinationKWMTKHKKLSAIPVS
HHHHHCCCCCCCCHH
47.60-
413UbiquitinationKLSAIPVSAFCNSET
CCCCCCHHHHCCCCC
15.4121890473
421UbiquitinationAFCNSETKSQFEKFV
HHCCCCCHHHHHHHH
37.90-
434UbiquitinationFVRFCFIKKDSTLDA
HHHHHHCCCCCHHHH
30.21-
435UbiquitinationVRFCFIKKDSTLDAA
HHHHHCCCCCHHHHH
52.69-
437PhosphorylationFCFIKKDSTLDAAEE
HHHCCCCCHHHHHHH
39.4922210691
447 (in isoform 1)Ubiquitination-49.8421890473
447UbiquitinationDAAEEIIKAWSVQKS
HHHHHHHHHHHHCCC
49.8421890473
453UbiquitinationIKAWSVQKS------
HHHHHHCCC------
56.85-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of KAT3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of KAT3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KAT3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MSS4_HUMANRABIFphysical
16169070
PGM1_HUMANPGM1physical
26344197
PGM5_HUMANPGM5physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KAT3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-108 AND LYS-116, AND MASSSPECTROMETRY.

TOP